- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Technology Director Dr. Sung Choi to Discuss Nanowire Manufacture at 10th Annual Industry Expo
Enable IPC Corporation (OTCBB: EIPC) today announced that Dr. Sung Choi, Director of Technology, is scheduled to discuss his unique method of creating nanowires in a poster session at the Nanotech 2007 Conference in Santa Clara, California at 4:00 p.m. on Tuesday, May 22, 2007. Dr. Choi's nanowires are free-standing poles, each approximately 1/1000th the diameter of a human hair, and are a key technology for Enable IPC's microbatteries. Enable IPC has a patent pending on the company's microbattery design. Microbatteries are used in some "smart" cards, RFID tags, small medical devices and a number of other applications. The microbattery market has been independently estimated to grow to over $3 billion in the next six years.
The conference will take place at the Santa Clara Convention Center from May 20th - 24th. More information can be found at http://www.nsti.org/Nanotech2007 .
Separately, Enable IPC recently announced that CEO David Walker will be speaking at the Friedland Capital Alternative Energy Conference on Tuesday, April 24, in New York City.
To be added to Enable IPC's corporate update list for shareholders and interested investors, please send an e-mail to .
About Enable IPC Corp.
Enable IPC Corporation has a patent application on a proprietary concept that combines thin film manufacture with nanotechnology to produce a microbattery that the company believes will significantly out perform comparable products and revolutionize the microbattery industry. The company's product is expected to be smaller, cheaper, longer lasting, and more environmentally friendly than comparable existing products. The microbattery is ideal for use in multiple applications including healthcare products, RFID tags, and smart cards.
Forward-Looking Statements: This release contains forward-looking statements, such as "believes," "expected" and similar terminology, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties which could cause actual results that the Company achieves to differ materially from any of the forward-looking statements. Such risks and uncertainties, include, but are not limited to, the following: the timely development and market acceptance of products and technologies, the ability to secure additional sources of financing, the difficulties in forecasting results from development efforts, difficulties in accurately estimating market growth, the impact of changing economic conditions, business conditions in the microbattery industry and others identified in our Annual Report on Form 10-KSB, as amended, and other Securities and Exchange Commission filings. The company undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For more information, please click here
Enable IPC Corporation
800-631-8127 (Investor Relations)
Copyright © Market WireIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015
Battery Technology/Capacitors/Generators/Piezoelectrics/Thermoelectrics/Energy storage
X-rays and electrons join forces to map catalytic reactions in real-time: New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions June 29th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015